# Title

 Food and Drugs. PART 226â€”CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES


# ID

 CFR-2018-title21-vol4.Pt. 226


# Structured Analysis Summary

| Type        | Values                                                                                      |
|:------------|:--------------------------------------------------------------------------------------------|
| Constraints | ['less than', 'within', 'at least', 'before', 'after']                                      |
| Duration    | ['2.0 year']                                                                                |
| Condition   | ['subject to', 'until', 'where', 'provided that', 'when', 'if']                             |
| Entities    | ['Equipment', 'Distribution', 'Laboratory', 'Food', 'Appropriate', 'Suitable', 'Packaging'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                              |
|:--------------|:-------------------------------------------------------------------------------------------------------------------------------------|
| before        | the raw materials and Type A medicated article(s) before , during, and after production.                                             |
| after         | and Type A medicated article(s) before, during, and after  production.                                                               |
| within        | component(s) with the first five consecutive batches assaying within the limitations, followed thereafter by assay of representative |
| less than     | thereafter by assay of representative samples of not less than  5 percent of all batches produced.                                   |
| within        | When any batch does not assay  within limitations, each batch should again be assayed until                                          |
| within        | When any batch does not assay  within limitations, each batch should again be assayed until                                          |
| at least      | and shall be maintained for a period of at least 2 years after distribution by the manufacturer of                                   |
| after         | for a period of at least 2 years after distribution by the manufacturer of the Type A                                                |
| at least      | medicated article(s) produced and shall be retained for at least 2 years after distribution by the manufacturer has                  |
| after         | shall be retained for at least 2 years after  distribution by the manufacturer has been completed.                                   |
| at least      | Such records shall be retained for  at least 2 years after the date of the shipment                                                  |
| after         | shall be retained for at least 2 years after the date of the shipment by the manufacturer                                            |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                    |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.0 year   | Appropriate receipt and inventory records shall be maintained for 2 years, and such records shall show the origin of any drug components, the manufacturer's control number (if any), the dates and batches in which they were used, and the results of any testing of them.                               |
| 2.0 year   | Such records shall be retained in the possession of the manufacturer and shall be maintained for a period of at least 2 years after distribution by the manufacturer of the Type A medicated article(s) has been completed.                                                                                |
| 2.0 year   | (b) A separate batch-production and control record shall be prepared for each batch or run of Type A medicated article(s) produced and shall be retained for at least 2 years after distribution by the manufacturer has been completed.                                                                   |
| 2.0 year   | Such records shall be retained for at least 2 years after the date of the shipment by the manufacturer and shall include the name and address of the consignee, the date and quantity shipped, and the manufacturing dates, control numbers, or marks identifying the Type A medicated article(s) shipped. |
| 2.0 year   | Records shall be maintained for a period of 2 years of all written or verbal complaints concerning the safety or efficacy of each Type A medicated article(s).                                                                                                                                             |


## Condition

| Condition     | Context                                                                                                                                |
|:--------------|:---------------------------------------------------------------------------------------------------------------------------------------|
| when          | the production of a Type A medicated article(s) when adequate inspection and checking procedures or other quality                      |
| subject to    | Type A medicated articles requiring approved NADAs are subject to  the requirements of &#167;&#8201;514.80 of this chapter.            |
| subject to    | A medicated articles listed in the index are subject to  the requirements of &#167;&#8201;516.165 of this chapter.                     |
| when          | (b) Provide adequate lighting and ventilation, and  when necessary for the intended production or control purposes,                    |
| if            | safeguards to avoid any buildup above the spec if ied levels of the drug components in any                                             |
| until         | such Type A medicated article(s) shall not begin until it has been determined that proper control procedures                           |
| until         | within limitations, each batch should again be assayed until  five consecutive batches are within limitations.                         |
| provided that | the preparation of the Type A medicated article(s), provided that the variations are stated in the master formula;                     |
| when          | continuous production run, any additional manufacturing directions including, when indicated, the settings of equipment that have been |
| if            | or destruction of the Type A medicated article(s), if  necessary.                                                                      |
| where         | be evaluated by competent and responsible personnel and, where  indicated, appropriate action shall be taken.                          |


## Entities

| Entities     | Context                                                                        |
|:-------------|:-------------------------------------------------------------------------------|
| Food         | Food  and Drugs.                                                               |
| Equipment    | Equipment .                                                                    |
| Equipment    | Equipment used for the manufacture, processing, packaging, bulk shipment,      |
| Appropriate  | Appropriate receipt and inventory records shall be maintained for              |
| Laboratory   | Laboratory  controls.                                                          |
| Laboratory   | Laboratory controls shall include the establishment of adequate specifications |
| Laboratory   | Laboratory controls shall include: (a) The establishment of master             |
| Suitable     | Suitable expiration dates shall appear on the labels of                        |
| Packaging    | Packaging  and labeling.                                                       |
| Distribution | Distribution  records.                                                         |


